Search for stock quotes, financial statistics and more
Raymond James analyst David Novak likes the quarterly results from BioSyent (BioSyent Stock Quote, ... Read More
If you’re looking for a pharma name with solid prospects you should be checking out Canadian compa... Read More
Another strong quarter has Cantor Fitzgerald Canada analyst Scott Curtis feeling bullish about BioSy... Read More
Cantor Fitzgerald Canada analyst Scott Curtis says that as the result of years of marketing and prom... Read More
BioSyent (TSXV:RX) today announced Q2 results that are indicative of the revenue and earnings moment... Read More
Share
Tweet
pin
Share